Body composition as a potential biomarker of recurrence risk in patients with triple-negative breast cancer
Authors:
Open Access
- 11 March 2025
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 211 (3) , 627-635
Abstract
Background: Triple-negative breast cancer (TNBC) patients are at increased risk for recurrence compared to other subtypes of breast cancer. Previous evidence showed that adiposity may contribute to worsened cancer control. Current measures of obesity, such as body-mass index (BMI), are poor surrogates of adiposity, while visceral-to-subcutaneous adiposity ratio (VSR), which can be measured from routine computed tomography (CT) imaging, is a direct adiposity measure. We hypothesized that VSR is a stronger predictor of recurrence compared with BMI in patients with TNBC. Materials and methods: This study includes 162 women with stage I-III TNBC who completed standard of care therapy. Measures of body composition, including VSR, visceral adiposity (VA), and subcutaneous adiposity (SA), were estimated using a semi-automated quantitative imaging tool on CT images of the abdomen at the level of L2-L3. Anthropometric measures included BMI and waist circumference and were obtained from CT images. Associations of adiposity measures and recurrence risk were assessed using Fine and Gray competing risk models with death as a competing risk and age at diagnosis and clinical disease stage as covariates. Results: During a median follow-up time of 7.1 years, 55 patients had recurrence. The median BMI at baseline was 30.2 [Quartiles: 26.3–35.2]. Body composition was not associated with overall or locoregional recurrence. VSR was significantly associated with an increased risk of distant recurrence, with a subdistribution hazard ratio of 4.25 (95% CI: 1.06–17.02), p = 0.041. By contrast, BMI was not associated with any recurrence risk. Conclusion: Consistent with our hypothesis, VSR was associated with a significant risk of distant recurrence and therefore may be a prognostic biomarker. Future directions include interventions targeting VSR reduction among patients with TNBC and VSR-directed therapy modulation.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R00CA201304, P30CA068485, P50CA098131, R00CA201304, P30CA068485, P50CA098131)
- American Cancer Society (Research Scholar Grant)
This publication has 60 references indexed in Scilit:
- The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort studyEuropean Journal of Epidemiology, 2023
- Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerCell Reports, 2021
- Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health InitiativeCancer, 2020
- Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Adipose Tissue Distribution and Survival Among Women with Nonmetastatic Breast CancerObesity, 2019
- Body mass index and weight change in relation to triple-negative breast cancer survivalCancer Causes & Control, 2015
- Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancerObesity Research & Clinical Practice, 2013
- Molecular and morphologic characterization of superficial‐ and deep‐subcutaneous adipose tissue subdivisions in human obesityObesity, 2013
- Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancerCancer, 2012
- The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic riskDiabetologia, 2012